Maud Jourdain
Overview
Explore the profile of Maud Jourdain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angibaud M, Grimal A, Bataille E, Huon J, Jourdain M, Gaultier A, et al.
BMJ Open
. 2025 Mar;
15(3):e085626.
PMID: 40074273
Objective: To assess whether patient experience is better for patients followed in a primary care team (PCT) than for patients with traditional follow-up in usual care. Design: A cross-sectional survey...
2.
Angibaud M, Jourdain M, Girard S, Rouxel L, Mouhib A, Nogueira A, et al.
BMC Prim Care
. 2024 Apr;
25(1):103.
PMID: 38561676
Background: The World Health Organization supports interprofessional collaboration in primary care. On over the past 20 years, community pharmacists had been taking a growing number of new responsibilities and they...
3.
Bouton C, Journeaux M, Jourdain M, Angibaud M, Huon J, Rat C
BMC Prim Care
. 2023 Nov;
24(1):253.
PMID: 38031014
Background: In a period of change in the organization of primary care, Interprofessional Collaboration (IPC) is presented as one of the solutions to health issues. Although the number of inter-professional...
4.
Hoarau E, Latypova X, Jourdain M, Isidor B
Eur J Med Genet
. 2022 Sep;
65(11):104606.
PMID: 36100158
Preconception genetic testing is carried out to inform couples on their carrier status for recessive or X-linked genetic disease, and aims to extend their possible reproductive choices. These genetic tests...
5.
Nguyen-Soenen J, Jourdain M, Fournier J
Ann Pharmacother
. 2021 Sep;
56(7):800-808.
PMID: 34553640
Background: Proton pump inhibitor (PPI) deprescribing is recommended in case of inappropriate use. Patient education materials are key elements in the deprescribing process. Objective: The study objective was to develop...
6.
Bonneau V, Nizon M, Latypova X, Gaultier A, Hoarau E, Bezieau S, et al.
Orphanet J Rare Dis
. 2021 Mar;
16(1):130.
PMID: 33712027
Background: Until very recently, preconception genetic testing was only conducted in particular communities, ethnic groups or families for which an increased risk of genetic disease was identified. To detect in...
7.
Lefevre L, Jourdain M, Fournier J
Prim Health Care Res Dev
. 2019 Oct;
20:e143.
PMID: 31640822
Aim: Our objective was to explore the processes and determinants leading physicians to integrate estimated glomerular filtration rate (eGFR) in their drug prescriptions. Background: Access to patients' eGFR would allow...
8.
Merkus S, Hoedeman R, Maeland S, Weerdesteijn K, Schaafsma F, Jourdain M, et al.
BMJ Open
. 2017 Jul;
7(7):e015025.
PMID: 28733298
Objectives: To develop hypotheses about whether there are patient-related factors that influence physicians' decision-making that can explain why some patients with severe subjective health complaints (SHCs) are more likely to...
9.
L Werner E, Merkus S, Maeland S, Jourdain M, Schaafsma F, Canevet J, et al.
BMJ Open
. 2016 Jul;
6(7):e011316.
PMID: 27417198
Objectives: A comparison of appraisals made by general practitioners (GPs) in France and occupational physicians (OPs) and insurance physicians (IPs) in the Netherlands with those made by Scandinavian GPs on...
10.
Kandel O, Ripault A, Jourdain M, Bouche G
Rev Prat
. 2008 Sep;
58(12 Suppl):19-24.
PMID: 18773661
The French are the biggest consumers of psychoactive drugs in Europe. French general practitioners were accused of being partly responsible: it was stressed that psychoactive drugs would be a means...